InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,728.74
(
0.18%
)
US TECH 100
19,421.60
(
0.52%
)
Dow Jones
42,130.68
(
0.01%
)
Brent Oil
74.34
(
0.81%
)
Bitcoin
63,832.59
(
0.80%
)
Post# of 964
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

midastouch017

Send PM Follow Ignore
Followers 144
Posts 27709
Boards Moderated 3
Alias Born 02/07/2004

midastouch017

Re: None

Tuesday, 02/09/2021 1:36:04 AM

Tuesday, February 09, 2021 1:36:04 AM

Post# of 964
TCT Meeting Presentations

Gamida Cell Ltd (NASDAQ: GMDA): results of the Phase 1 study of omidubicel versus standard myeloblative umbilical cord blood transplantation in patients with hematologic malignancies undergoing allogeneic bone marrow transplant (Tuesday, Feb. 9 at 4:45-5 p.m.)

https://fintechzoom.com/fintech_news_nasdaq/nasdaq-today-regeneron-fda-decision-earnings-ipos-and-conference-presentations-in-the-spotlight/
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up